var data={"name":"Transfusion medicine","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Blood components","type":"SUBSECTION","items":[{"name":"Clinical and laboratory aspects of platelet transfusion therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-and-laboratory-aspects-of-platelet-transfusion-therapy"},{"name":"Clinical use of Cryoprecipitate","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-cryoprecipitate"},{"name":"Clinical use of plasma components","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-plasma-components"},{"name":"Granulocyte transfusions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=granulocyte-transfusions"},{"name":"Intraoperative transfusion of blood products in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intraoperative-transfusion-of-blood-products-in-adults"},{"name":"Pathogen inactivation of blood products","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogen-inactivation-of-blood-products"},{"name":"Plasma derivatives and recombinant DNA-produced coagulation factors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=plasma-derivatives-and-recombinant-dna-produced-coagulation-factors"},{"name":"Red blood cell transfusion in adults: Storage, specialized modifications, and infusion parameters","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=red-blood-cell-transfusion-in-adults-storage-specialized-modifications-and-infusion-parameters"}]},{"name":"Blood donor","type":"SUBSECTION","items":[{"name":"Blood donor screening: Medical history","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=blood-donor-screening-medical-history"},{"name":"Blood donor screening: Procedures and processes to enhance safety for the blood recipient and the blood donor","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=blood-donor-screening-procedures-and-processes-to-enhance-safety-for-the-blood-recipient-and-the-blood-donor"},{"name":"Directed (designated) blood donation programs","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=directed-designated-blood-donation-programs"},{"name":"Pretransfusion testing for red blood cell transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pretransfusion-testing-for-red-blood-cell-transfusion"},{"name":"Surgical blood conservation: Preoperative autologous blood donation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=surgical-blood-conservation-preoperative-autologous-blood-donation"},{"name":"The incompatible crossmatch","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-incompatible-crossmatch"}]},{"name":"Granulocyte transfusion","type":"SUBSECTION","items":[{"name":"Granulocyte transfusions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=granulocyte-transfusions"}]},{"name":"Infectious risk","type":"SUBSECTION","items":[{"name":"Blood donor screening: Laboratory testing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=blood-donor-screening-laboratory-testing"},{"name":"Hepatitis C and transfusion: A 'lookback' primer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hepatitis-c-and-transfusion-a-lookback-primer"},{"name":"Risk of HIV from blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-of-hiv-from-blood-transfusion"}]},{"name":"Intravenous immune globulin","type":"SUBSECTION","items":[{"name":"Overview of intravenous immune globulin (IVIG) therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-intravenous-immune-globulin-ivig-therapy"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Fibrin sealants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=fibrin-sealants"}]},{"name":"Plasma exchange","type":"SUBSECTION","items":[{"name":"Therapeutic apheresis (plasma exchange or cytapheresis): Complications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=therapeutic-apheresis-plasma-exchange-or-cytapheresis-complications"},{"name":"Therapeutic apheresis (plasma exchange or cytapheresis): Indications and technology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=therapeutic-apheresis-plasma-exchange-or-cytapheresis-indications-and-technology"}]},{"name":"Platelet transfusion","type":"SUBSECTION","items":[{"name":"Clinical and laboratory aspects of platelet transfusion therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-and-laboratory-aspects-of-platelet-transfusion-therapy"},{"name":"Refractoriness to platelet transfusion therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=refractoriness-to-platelet-transfusion-therapy"}]},{"name":"Red cell transfusion","type":"SUBSECTION","items":[{"name":"Indications and hemoglobin thresholds for red blood cell transfusion in the adult","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=indications-and-hemoglobin-thresholds-for-red-blood-cell-transfusion-in-the-adult"},{"name":"Intraoperative transfusion of blood products in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intraoperative-transfusion-of-blood-products-in-adults"},{"name":"Leukoreduction to prevent complications of blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=leukoreduction-to-prevent-complications-of-blood-transfusion"},{"name":"Massive blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=massive-blood-transfusion"},{"name":"Oxygen carriers as alternatives to red blood cell transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=oxygen-carriers-as-alternatives-to-red-blood-cell-transfusion"},{"name":"Red blood cell antigens and antibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=red-blood-cell-antigens-and-antibodies"},{"name":"Red blood cell transfusion in adults: Storage, specialized modifications, and infusion parameters","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=red-blood-cell-transfusion-in-adults-storage-specialized-modifications-and-infusion-parameters"},{"name":"Reducing bleeding and minimizing blood transfusion during surgery","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=reducing-bleeding-and-minimizing-blood-transfusion-during-surgery"},{"name":"The approach to the patient who refuses blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-approach-to-the-patient-who-refuses-blood-transfusion"}]},{"name":"Special techniques","type":"SUBSECTION","items":[{"name":"General principles of home blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-home-blood-transfusion"},{"name":"Leukoreduction to prevent complications of blood transfusion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=leukoreduction-to-prevent-complications-of-blood-transfusion"},{"name":"Surgical blood conservation: Blood salvage","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=surgical-blood-conservation-blood-salvage"},{"name":"Surgical blood conservation: Intraoperative hemodilution","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=surgical-blood-conservation-intraoperative-hemodilution"},{"name":"The path to safer home transfusion: Standard operating procedures","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-path-to-safer-home-transfusion-standard-operating-procedures"}]},{"name":"Transfusion reactions","type":"SUBSECTION","items":[{"name":"Approach to the patient with a suspected acute transfusion reaction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-patient-with-a-suspected-acute-transfusion-reaction"},{"name":"Hemolytic transfusion reactions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hemolytic-transfusion-reactions"},{"name":"Immunologic transfusion reactions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunologic-transfusion-reactions"},{"name":"Management of non-Rhesus (D) red blood cell alloantibodies during pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-non-rhesus-d-red-blood-cell-alloantibodies-during-pregnancy"},{"name":"Management of pregnancy complicated by Rhesus (D) alloimmunization","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-pregnancy-complicated-by-rhesus-d-alloimmunization"},{"name":"Overview of Rhesus D alloimmunization in pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-rhesus-d-alloimmunization-in-pregnancy"},{"name":"Prevention of Rhesus (D) alloimmunization in pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-rhesus-d-alloimmunization-in-pregnancy"},{"name":"Red blood cell antigens and antibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=red-blood-cell-antigens-and-antibodies"},{"name":"Transfusion-associated circulatory overload (TACO)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transfusion-associated-circulatory-overload-taco"},{"name":"Transfusion-associated graft-versus-host disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transfusion-associated-graft-versus-host-disease"},{"name":"Transfusion-related acute lung injury (TRALI)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transfusion-related-acute-lung-injury-trali"}]}]}